跳至主要内容
临床试验/NCT06565351
NCT06565351已完成不适用

Feasibility of Replacing 99mTc-DTPA GFR Measurements With eGFR From s-Cystatin C in Individuals With Spinal Cord Injuries

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 248 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
248
试验地点
1
主要终点
Estimated clearance of Cystatin C (eGFR cystatin C)

研究概览

简要总结

  • In individuals with spinal cord injury (SCI) kidney function defined as Glomerular Filtration Rate (GFR) is monitored by injection of e.g.99mDTPA and subsequent blood sampling (DTPA-clearance)
  • GFR calculated from plasma samples of the endogenous substance s-Cystatin C (eGFR cystatin C) was compared to DTPA-clearance in 248 individuals with SCI.
  • It is concluded that eGFR based on plasma s-cystatin C can replace the more tedious 99mDTPA-clearance procedures in individuals with SCI

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Neurogenic bladder dysfunction due to spinal cord injury

排除标准

  • 未提供

结局指标

主要结局

Estimated clearance of Cystatin C (eGFR cystatin C)

时间窗: through study period (2 years)

The estimated clearance of cystatin (eGFR) C is calculated from s-cystatin C and the age and height and weight of the individual. It is corrected for Body Surface area. In this study it is compared to the Gold Standard examination DTPA-clearance

次要结局

  • Test/ retest variability of eGFR cystatin C(Up to three months)
  • Long term repeatability of eGFR cystatin C(Up to three years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ulrik Bjoern Andersen

Senior Consultant

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验